Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of liraglutide and radiofrequency cavitation for abdominal obesity
IRCT20251003067486N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Nov 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of liraglutide in obesity (2 arms), sponsored by Islamic Azad University. Started Nov 2025; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on IRCT20251003067486N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251003067486N1.